Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Label update approved for Tysabri to include anti-JC virus antibody status

May 24, 2012

Seattle Genetics' Adcetris NDS accepted for review by Health Canada

May 24, 2012

Health Canada grants Apricus Biosciences meeting for nail fungus therapy

May 14, 2012

Apricus Biosciences to meet with Health Canada on Femprox

May 9, 2012

Boston Scientific stent system set for launch in Canada

April 26, 2012

Fampyra launched in Canada

April 12, 2012

Lilly obtains approval in Canada for testosterone replacement therapy

April 12, 2012

Biovest to file marketing application in Canada

April 11, 2012

Health Canada approves grass pollen immunotherapy

March 22, 2012

Health Canada approves diclofenac therapy

March 19, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 26, 2025.
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 26, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...